센시리온 홀딩 AG (SENS) 주가

센시리온 홀딩 AG(SENS)는 NYSE MKT에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $9.43 (+4.08%), 시가총액 $0.31B, 52주 최저~최고 $0.41 ~ $8.47.

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. Its products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1

핵심 지표

• 현재가: $9.43 (+4.08%)
• 시가총액: $0.31B
• 52주 최저~최고: $0.41 ~ $8.47
• 섹터: Healthcare
• 산업: Medical Devices
• 거래소: NYSE MKT

센시리온 홀딩 AG의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

센시리온 홀딩 AG 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 3.5

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 7.65
• 순이익률: -2.14%
• 영업이익률: -2.72%

자주 묻는 질문